en

PRODUCT DETAIL

Mounjaro 5 mg injekčný roztok v naplnenom pere

Code 2086E
MA number EU/1/22/1685/004
Product Form: sol inj 2x0,5 ml/5 mg (pero napl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
MAH, country: Eli Lilly Nederland B.V., Netherland
Therapeutic Class: 18 - ANTIDIABETICA (VRÁTANE INZULÍNU)
ATC:
A ALIMENTARY TRACT AND METABOLISM
A10 DRUGS USED IN DIABETES
A10B Blood glucose lowering drugs, excl. insulins
A10BX Other blood glucose lowering drugs, excl. insulins
A10BX16 Tirzepatide
Shelf life: 24
Route of admin.: Subcutaneous use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 15.09.2022
Validity: 15.09.2027
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 27.10.2023
eu-flag.png sk-flag.png